M. T. Pulido-Rios

Characterization of putative 5‐ht7 receptors mediating direct relaxation in Cynomolgus monkey isolated jugular vein

R. Eglen, E. Leung, L. Walsh, 1996, British journal of pharmacology.

Preclinical efficacy of THRX-200495, a dual pharmacology muscarinic receptor antagonist and β(2)-adrenoceptor agonist (MABA).

M. Mammen, W. Martin, S. Hegde, 2012, Pulmonary pharmacology & therapeutics.

Comparison of 5-HT4 receptors in guinea-pig colon and rat oesophagus: effects of novel agonists and antagonists

E. Wong, R. Eglen, D. Bonhaus, 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

Duration by Design: Discovery of Revefenacin, the First-in-Class Nebulized Once-Daily Bronchodilator for the Treatment of Patients With COPD

M. Mammen, E. Moran, Yu-hua Ji, 2016 .

Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist.

M. Mammen, J. Jasper, S. Hegde, 2009, European journal of pharmacology.

Application of the classical Einthoven model of bronchoconstriction to the study of inhaled bronchodilators in rodents.

W. Martin, S. Hegde, M. T. Pulido-Rios, 2011, Journal of pharmacological and toxicological methods.

5‐Hydroxytryptamine Receptor Assays

G. Martin, Katherine W. Figueroa, M. T. Pulido-Rios, 2009, Current protocols in pharmacology.